knowledge -WSS

knowledge

author：Wikipedia 2025-10-02 12:01:59 - browse：223

Illustration of a dollar sign with arrows. — Adobe

Health insurers are telling shareholders that they are ramping up the use of artificial intelligence and are hiring talent to implement the technology across their organizations. They say their artificial intelligence models can increase efficiency and “cut costs,” but they refused to discuss what models they’re using, how those models were developed, or exactly what they’re using them for.

Centene, for instance, says, it is “investing in artificial intelligence and machine learning technologies to improve the health of our members and contain rising healthcare costs.” The insurer, whose plans cover more than 28 million Americans, noted that its large footprint, particularly in government-sponsored programs, puts it “in a unique position to use data to develop models that predict a wide range of health outcomes.”

A STAT review of regulatory filings from publicly traded health insurers showed that several of them, including Elevance, Molina, and Cigna, are investing in AI with the goal of saving money. Elevance has hired nearly 500 people to work exclusively on AI. However, all five of the insurers STAT contacted declined to elaborate on how they are using AI.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： How to use technology to prevent future drug shortages

WSS

FDA gives detailed accounting of AI

Friends ask where James Watson's attitudes about race came from

Friends ask where James Watson's attitudes about race came from

Researchers explore possible ties between long Covid, menopause

Why failed clinical trials don’t always spell doom for a new drug

Eli Lilly expects to double planned employment in Boston center

focus

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

leisure time

State Dept. review finds Biden bears some blame for Afghanistan failures

The best solution to the drug shortages problem

How to save PrEP access — and even expand it

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

Peter Hotez and the public health issue of online harassment

Shkreli is convicted of fraud. Can pharma finally slam the door on him?

Dobbs anniversary: the lost opportunity of abortion as health care

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

How to save PrEP access — and even expand it

STAT Summit: Michael J. Fox on progress in Parkinson's research

hotspot

How climate

STAT Readout Newsletter: Today's biggest biotech updates

Lawmakers consider Medicare pay reforms for doctors

American woman, child freed after being kidnapped in Haiti last month

Maui's cultural, historic landmarks damaged in the devastating wildfires

Why health workers in Gaza are injured or die at high rates

hotspot

explore

hotspot

focus